Do people with MS have a higher risk of cancer?
A new study has found that some cancers are slightly more common in people with multiple sclerosis (MS) than in… Read More »Do people with MS have a higher risk of cancer?
A new study has found that some cancers are slightly more common in people with multiple sclerosis (MS) than in… Read More »Do people with MS have a higher risk of cancer?
In new research, a team led by University of Cincinnati researchers has identified a potential new way to make radiation… Read More »Drug improves effectiveness of radiation for lung cancer that has spread to the brain
A drug approved to treat the blood cancer of multiple myeloma may offer a safe and effective way to reduce… Read More »Clinical trial successfully repurposes cancer drug to treat inherited bleeding disorder
A drug that delivers chemotherapy directly to tumors has shown impressive activity against some of the hardest-to-reach cancer cells: those… Read More »Antibody-drug conjugate effective against brain metastases in patients with HER2-positive breast cancer
(Bloomberg) – O medicamento experimental da Pfizer (PFIZ34) para perda de peso em pacientes com câncer demonstrou ajudá-los a recuperar… Read More »Medicamento da Pfizer ajuda pacientes com câncer a ganhar peso, mostra estudo
Interim data from a Phase I dose-escalation trial of mRNA cancer immunotherapy (mRNA-4359) are promising in patients with advanced solid… Read More »Experimental mRNA cancer vaccine shows potential for patients with advanced cancer in phase 1 trial
In a study by the University of Utah’s Huntsman Cancer Institute and New York University’s Langone Perlmutter Cancer Center, researchers… Read More »Can chatbots help with genetic testing for cancer risk?
The lotus leaf is a pioneer in the field of self-cleaning and water repellency. Water droplets practically float on its… Read More »Bioengineers develop lotus-leaf-inspired system to advance study of cancer cell clusters
A team of researchers at New York University Abu Dhabi, led by Professor Sehamuddin Galadari, has discovered that the tumor… Read More »Tumor suppressor protein Par-4 triggers a unique cell death pathway in cancer cells
The recent approval by the U.S. Food and Drug Administration of lifileucel, the first commercial tumor-infiltrating lymphocyte (TIL) therapy for… Read More »Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment